Welcome to CDC stacks | Antibiotic Resistance Patterns of Bacterial Isolates from Blood in San Francisco County, California, 1996-1999 - 13752 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Antibiotic Resistance Patterns of Bacterial Isolates from Blood in San Francisco County, California, 1996-1999
  • Published Date:
    Feb 2002
  • Source:
    Emerg Infect Dis. 8(2):195-201.
Filetype[PDF-85.73 KB]


Details:
No Related Documents.
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 48, no. 30, August 6, 1999
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    August 6, 1999
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 48, no. 30
    File Type:
    Filetype[PDF - 519.13 KB]
  2. National Antimicrobial Resistance Monitoring System : enteric bacteria 1998 annual report
    Corporate Author:
    National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases. Foodborne and Diarrheal Diseases Branch.
    Published:
    August 9, 1999
    Description:
    In 1998, there were 1476 Salmonella isolates, 315 E. coli O157:H7 isolates, and 382 Campylobacter isolates from humans submitted to the National Antimicrobial Resistance Monitoring System:Enteric Bacteria (NARMS). Twenty-seven percent of Salmonella i...
    File Type:
    Filetype[PDF - 1.74 MB]
  3. ICEID 2002 program and abstracts book; International Conference on Emerging Infectious Diseases, March 24-27, 2002, Hyatt Regency, Atlanta, Georgia, USA
    Corporate Author:
    American Society for Microbiology. Association of Public Health Laboratories (U.S.). CDC Foundation. Centers for Disease Control and Prevention (U.S.). Council of State and Territorial Epidemiologists. World Health Organization.
    Conference Author:
    International Conference on Emerging Infectious Diseases (2002 : Atlanta, GA)
    Published:
    2002
    Description:
    "Organized by the Centers for Disease Control and Prevention (CDC), the Council of State and Territorial Epidemiologists CSTE), the CDC Foundation (CDCF), the Association of Public Health Laboratories (APHL), and the World Health Organization (WHO), ...
    File Type:
    Filetype[PDF - 1.98 MB]
  4. Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Levine, Orin S.; Schwartz, Benjamin; Van Beneden, Chris A.; Whitney, Cynthia G.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases.. National Immunization Program (Centers for Disease Control and Prevention). Division of Epidemiology and Surveillance..
    Published:
    October 6, 2000
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-9 PMID:11055835:MODS 11055835
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use among infants and young children. CDC's Advisory Committee on Immunization Practices (ACIP) recommen...
    File Type:
    Filetype[PDF - 317.21 KB]
  5. Preventing pneumococcal disease among infants and young children : ecommendations of the Advisory Committee on Immunization Practices (ACIP).
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    10/06/2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-9):1-35.
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use among infants and young children. CDC's Advisory Committee on Immunization Practices (ACIP) recommen...
    Status:
    superseded
    File Type:
    Filetype[PDF - 317.21 KB]